Moventig (naloxegol)
- Region
- 🇪🇺 EU
- Active substance
- naloxegol
- Company
- Grunenthal GmbH
- Status
- Authorised
- Therapeutic area
- Constipation; Opioid-Related Disorders
- EU approval
- Sun 07 Dec 2014
- Application
- EMEA/H/C/002810
- ATC
- A06AH03
- Official record
- www.ema.europa.eu
Indication
Treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).
Regulatory milestones
No milestones recorded in the last year.
Follow Moventig
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.